Publication for Epb42 and Nfe2
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| mmu | Epb42 | erythrocyte membrane protein band 4.2 | 13828 | [link] | ||
| mmu | Nfe2 | nuclear factor, erythroid derived 2 | 18022 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 27452471 | 0.98 | p42, p45) are expressed in the proliferating myoblast (Fig. S3) and significantly increased through the early stages of myoblast differentiation, similar to the differentiation of skeletal muscle satellite cells in the animal. |
| 0.97 | p42, p45), derived by differential exon splicing of a common pre-mRNA. | |
| 19397786 | 0.94 | p45 but not p42 (Figure 4C). |
| 28348272 | 0.92 | p45 and p42) contain a unique N-terminal beta-catenin-binding domain, while the Tcf1 short isoforms (p33 and p30) lack this domain and hence cannot interact with beta-catenin. |
| 24158514 | 0.89 | p42 and p45 isoforms displayed modest activities, whereas p42 did not repress the reporter activity in HepG2 cells. |
| 0.84 | p42, p45). | |
| 28588456 | 0.88 | P42) the second exposure (thus not covering the proliferative phase of cells labeled with BrdU at P45; Figure 3A). |
| 28652395 | 0.84 | p45 and p42) contain an N-terminal beta-catenin-binding domain, while the Tcf1 short isoforms (p33 and p30) lack this domain and hence cannot interact with beta-catenin. |
The preparation time of this page was 0.0 [sec].
